Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This randomized phase I trial is studying the side effects of celecoxib in treating
postmenopausal women with invasive breast cancer who are scheduled to undergo surgery at
Memorial Sloan-Kettering Cancer Center. Celecoxib may stop the growth of tumor cells by
blocking the enzymes necessary for tumor cell growth.